{
    "eid": "2-s2.0-84961889751",
    "title": "Bone health and HIV in resource-limited settings: A scoping review",
    "cover-date": "2016-01-01",
    "subject-areas": [
        {
            "$": "Virology",
            "@code": "2406"
        },
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        },
        {
            "$": "Oncology (nursing)",
            "@code": "2917"
        },
        {
            "$": "Oncology",
            "@code": "2730"
        },
        {
            "$": "Hematology",
            "@code": "2720"
        },
        {
            "$": "Immunology",
            "@code": "2403"
        }
    ],
    "keywords": [
        "Antiretroviral therapy",
        "Bone mineral density",
        "HIV",
        "Resource-limited settings",
        "Tenofovir",
        "Vitamin D"
    ],
    "authors": [
        "Flavia Kiweewa Matovu"
    ],
    "citedby-count": 21,
    "ref-count": 154,
    "ref-list": [
        "World Bank List of Economies.",
        "Report on the Global AIDS Epidemic 2013",
        "Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-analytic review",
        "HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: A population-based cohort study",
        "HIV infection and its association with an excess risk of clinical fractures: A nationwide case-control study",
        "Incident fractures in HIV-infected individuals: A systematic review and meta-analysis",
        "Bones, fractures, antiretroviral therapy and HIV topical collection on HIV/AIDS",
        "Osteoporosis and fracture risk associated with HIV infection and treatment",
        "Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025",
        "Public health impact of osteoporosis",
        "Mortality rates after incident non-traumatic fractures in older men and women",
        "An estimate of the worldwide prevalence, mortality and disability associated with hip fracture",
        "The diagnosis of osteoporosis",
        "Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures",
        "Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy",
        "Osteopenia in HIV-infected patients: Is it the disease or is it the treatment?",
        "HIV infection and bone mineral density in middle-aged women",
        "Bone disease and HIV infection",
        null,
        "Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals",
        "Emerging bone problems in patients infected with human immunodeficiency virus",
        "Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects [6]",
        "HIV: An underrecognized secondary cause of osteoporosis?",
        "Increasing clarity on bone loss associated with antiretroviral initiation",
        "Bone disease in HIV infection: A practical review and recommendations for HIV care providers",
        "Low Bone Mass Prevalence, Therapy Type, and Clinical Risk Factors in an HIV-Infected Brazilian Population",
        "Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: Cross-sectional surveys",
        "Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy",
        "Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase",
        "Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy",
        "Exercise and bone mass in adults",
        "Bone mineral density in women with depression",
        "Low lumbar bone mineral density in patients with major depression",
        "Endocrine complications of human immunodeficiency virus infection: Hypogonadism, bone disease and tenofovir-related toxicity",
        "HIV protease inhibitors induce senescence and alter osteoblastic potential of human bone marrow mesenchymal stem cells: Beneficial effect of pravastatin",
        "Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats",
        "Journal of Bone and Mineral Research.",
        "Role of T-cell reconstitution in HIV-1 antiretroviral therapy-induced bone loss",
        "Bone loss in the HIV-infected patient: Evidence, clinical implications, and treatment strategies",
        "Stable bone mineral density over 6 years in HIV-infected men treated with highly active antiretroviral therapy (HAART)",
        "Poverty is a risk factor for osteoporotic fractures",
        "High prevalence of and progression to low bone mineral density in HIV-infected patients: A longitudinal cohort study",
        "Prevalence and risk factors of low bone mineral density in Korean HIV-infected patients: Impact of abacavir and zidovudine",
        "21st Conference on Retroviruses and Oppor Tunistic Infections",
        "J Int AIDS Soc",
        "J West Afr Coll Surg",
        "Factors influencing bone mineral density in ARV-naive patients at Sanglah Hospital, Bali.",
        null,
        "Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients",
        "Bone turnover and bone mineral density in HIV-1 infected Chinese taking highly active antiretroviral therapy -a prospective observational study",
        "Reduced bone mineral density among ART-naive male patients with HIV in China",
        "Vitamin D status in young HIV infected women of various ethnic origins: Incidence of vitamin D deficiency and possible impact on bone density",
        "American Society for Bone and Mineral Research (ASBMR) 2014 Annual Meeting",
        "Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy",
        "Antivir Ther",
        "Prevalence of and risk factors for osteoporosis and fracture among a male HIV-infected population in the UK",
        "Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: Sensitivity and specificity of current guidelines on bone mineral density management",
        "Low bone mineral density in patients with well-suppressed HIV infection: Association with body weight, smoking, and prior advanced HIV disease",
        "Long-term use of protease inhibitors is associated with bone mineral density loss",
        "Vitamin D and Calcium attenuate bone loss with antiretroviral therapy initiation: A Randomized Trial",
        "Relative contribution of HIV infection, demographics and body mass index to bone mineral density",
        "Prevalence of and risk factors for low bone mineral density in untreated HIV infection: A substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial",
        "Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: A 3-year randomized trial",
        "Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-lamivudine: A randomized, 96-week trial",
        "Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study",
        "Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: AIDS Clinical Trials Group A5224s, a substudy of ACTG A5202",
        "Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: A substudy of the NEAT001/ANRS143 randomised trial",
        "Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia",
        "Less Bone Loss with Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study",
        "J Int AIDS Soc",
        "Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: Tenofovir versus non-tenofovir regimens",
        "Bone mineral density changes after 2 years of ARV treatment, compared to naive HIV-1-infected patients not on HAART",
        "Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen",
        "Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study",
        "Tenofovir renal toxicity targets mitochondria of renal proximal tubules",
        null,
        "The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy",
        "Tenofovir-induced renal tubular dysfunction presenting with hypocalcaemia",
        "The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: The first 4 years",
        "Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir"
    ],
    "affiliation": [
        {
            "affiliation-city": "Johannesburg",
            "affilname": "University of the Witwatersrand Faculty of Health Sciences",
            "affiliation-country": "South Africa"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kampala",
            "affilname": "Makerere University School of Public Health",
            "affiliation-country": "Uganda"
        },
        {
            "affiliation-city": "Kampala",
            "affilname": "Makerere University",
            "affiliation-country": "Uganda"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Johannesburg",
            "affilname": "Wits School of Public Health",
            "affiliation-country": "South Africa"
        }
    ],
    "funding": [
        "National Institute of Allergy and Infectious Diseases",
        "National Institute of Allergy and Infectious Diseases"
    ]
}